Amedisys (AMED) PT Raised to $340 at Jefferies After Earnings
Tweet Send to a Friend
Jefferies analyst Brian Tanquilut raised the price target on Amedisys (NASDAQ: AMED) to $340.00 (from $300.00) after the company reported ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
